Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nichi-Iko Pharmaceutical Co., Ltd.

http://www.nichiiko.co.jp/english

Latest From Nichi-Iko Pharmaceutical Co., Ltd.

Big Pharma Shouts, Generics And Biosimilars Whisper: M&A In 2023

“A lot of companies are hurting because of the higher interest rates,” one major CEO observed recently, summing up a year which saw little headline-grabbing news on the M&A front for generic and biosimilar sponsors.

C-Suite Speaks Commercial Strategies

Indian Leaders Climb Into Generics And Biosimilars Top 10

In a year that has seen significant changes throughout the generics and biosimilars industry ranking, the top 10 has welcomed two Indian off-patent leaders. Meanwhile, companies lower down our ranking have enjoyed mixed fortunes, leading to a number of significant movements in this year’s Generics Bulletin Top 50.

Outlook 2024 Biosimilars

Sunsho Acquisition Finally Paying Off For Towa

After several lackluster quarters, Towa’s acquisition of Sunsho Pharmaceutical is finally paying off for the Japanese generics firm.

Sales & Earnings Japan

Sawai Outlook Improves But Japanese Generics Continue To Suffer Under NHI Price Cuts

Japanese generics giant Sawai appears to be turning a corner, but the impact of National Health Insurance pricing revisions continues to hold the firm – and the rest of the country’s generics industry – back.

Sales & Earnings Japan
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
    • OTC, Consumer
  • Biotechnology
    • Large Molecule
      • Antibodies
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Other Names / Subsidiaries
    • Elmed Eisai Co., Ltd
    • Nichi-Iko Medical Practice Institution Co., Ltd.
    • Yakuhan Pharmaceutical Co., Ltd.
    • Nichi-Iko Pharma Tech Co., Ltd.
    • Omega Laboratories Limited
    • Sagent Pharmaceuticals Inc.
    • Nihon Iyakuhin Kogyo Co., Ltd.
UsernamePublicRestriction

Register